Go back

Antimicrobial-resistance initiative updates research agenda

Antifungal research and innovation added to remit of international funding partnership

The Joint Programming Initiative on Antimicrobial Resistance, an EU-backed global R&D funding partnership, has updated its strategic research agenda, with the main change being the addition of antifungal research and innovation.

“Invasive fungal infections are life-threatening and are of increasing importance due to the expanding population of immunosuppressed patients and the limited number of available antifungal treatments,” the strategy launched on 6 April says.

This article is only available to *Research Professional subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Alternatively, Pivot-RP users can log in and view the article via this link.